,

S-Equol 99% HPLC | CAS 531-95-3 | Bulk Ingredient Supply

AIHerba® B2B TECHNICAL SNAPSHOT
S-Equol ≥99% HPLC | CAS 531-95-3
(S)-(−)-Equol · Daidzein-derived specialty ingredient · Reference lot YGIF26072101
01. Product Name S-Equol ≥99% HPLC — high-purity, batch-qualified specialty ingredient for B2B formulation and analytical evaluation.
02. Assay / Purity (Method) Specification: purity ≥99% (HPLC).
Reference lot YGIF26072101: purity 100.0%
(COA-reported, method basis to be verified);
dry-basis assay 99.82% (HPLC; specification 98.0–102.0%).
Chiral S/R purity: pending batch-linked report.
03. Appearance White crystalline powder; reference lot: conforms (visual).
04. CAS / INCI CAS 531-95-3; molecular formula C15H14O3;
molecular weight 242.27 g/mol.
INCI designation, if applicable:
subject to intended cosmetic use and verification.
05. Botanical / Chemical Source Daidzein-derived S-Equol;
fermentation/biotransformation is described in the
upstream supplier presentation.
Manufacturing route and feedstock traceability
require supplier documentation.
06. Key Analytical Markers Reference lot: melting point 189°C;
specific rotation [α]D25 −23.53°
(measurement conditions to be verified);
loss on drying 0.15%; ethanol 197 ppm.
Enantiomeric composition not established
by the supplied conventional HPLC report.
07. Carrier / Composition High-purity S-Equol powder.
Carrier, excipient, processing-aid and allergen
declarations: pending written confirmation
for the offered grade.
08. Formulation Compatibility Powder intended for capsule/tablet and
specialty formulation evaluation.
Solubility, dissolution, particle-size distribution,
stability and water/oil dispersibility
require grade-specific validation;
no instant-soluble claim.
09. MOQ / Lead Time / Packaging MOQ: subject to project and stock confirmation.
Lead time: quotation-dependent.
Packaging: reference COA states
inner sterile bag and outer aluminum-foil bag;
commercial pack weights to be confirmed.
10. Technical Documentation Reference COA: YGIF26072101,
21 Jul 2026 production, 30.2 kg historical batch quantity.
Current commercial batch:
subject to verification.
Updated TDS, SDS, chiral HPLC, current-lot COA and
site certificates: status to be verified.
Technical Evidence Note:
2026 batch COA results apply only to reference lot
YGIF26072101, not to a confirmed current shipment.
Historical HPLC material is not batch-matched
to this reference lot. Request current-lot and
chiral identity evidence before qualification.
Bulk Supply & Technical Advisory
GMP Certified
HPLC Lab Tested
Global Logistics
Samples Available
AIHerba® | B2B PRODUCT TECHNICAL QUALIFICATION
S-Equol ≥99% HPLC | CAS 531-95-3

Reference-batch COA YGIF26072101 · Clear purity vs assay reporting · Chiral identity review · Supplier qualification pathway

01. B2B S-Equol Supply & Technical Qualification

AIHerba® supports technical evaluation and international B2B sourcing of (S)-Equol at a stated ≥99% HPLC purity specification. This page focuses on identity, lot-specific analytical evidence, production documentation and qualification requirements rather than consumer treatment claims.

The documented reference lot is YGIF26072101 (manufactured 21 July 2026; 30.2 kg batch quantity in its COA). Current saleable lot, inventory quantity, shipment date and current batch test results must be confirmed individually. AIHerba supplies through a manufacturing/sourcing arrangement; manufacturing site attribution and authorizations are documented separately.

Buyer pathway: request the relevant grade, destination, volume and documentation checklist; then review the current-lot COA before a production purchase.

02. What Is (S)-Equol? Chemical Identity

S-Equol is the (S) enantiomer of equol, a metabolite that can arise from microbial conversion of the soy isoflavone daidzein. It is a defined molecule, not equivalent to a generic soybean extract or a soy-isoflavone mixture.

Identity field Value
Name (S)-(−)-Equol / S-Equol
CAS 531-95-3
Molecular formula C15H14O3
Molecular weight 242.27 g/mol
Chemical category Chiral isoflavone metabolite

For distinctions between equol, S-Equol, R-Equol and soybean starting materials, consult the Equol identity guide.

03. S-Equol vs. R-Equol and Racemic Equol

S-Equol and R-Equol share a molecular formula but differ in stereochemistry. Racemic equol contains both enantiomers. A high result from a conventional, non-chiral HPLC purity assay cannot, on its own, establish S-enantiomeric purity.

Term Supplier qualification question
S-Equol Is the S configuration established with validated identity evidence?
R-Equol Has the alternative enantiomer been assessed?
Racemic Equol Is the S:R ratio known and declared?
Conventional HPLC purity Does the method resolve both enantiomers?
Chiral HPLC Are standards, peak assignment and method suitability documented?
Evidence boundary: the supplied 2026 COA reports a specific rotation of −23.53°, but a standalone chiral separation report for that lot was not supplied.

04. Product Specification & Available Grade

The supplied company specification identifies S-Equol as a white powder with purity ≥99% by HPLC. The 2026 reference COA contains an HPLC purity specification of ≥99% and a separate dry-basis assay acceptance range of 98.0–102.0%.

Specification item Current documented specification Evidence
HPLC purity ≥99% 2026 reference COA
Assay on dried basis 98.0–102.0% 2026 reference COA
Appearance White crystalline powder 2026 reference COA
Loss on drying ≤1.0% 2026 reference COA
Ethanol residual solvent <200 ppm 2026 reference COA
Particle size 95% passes 60 mesh (2026 COA); older specification lists 100% passes 100 mesh Conflict: latest signed grade-specific TDS required

Unverified 90%, water-dispersible and oil-dispersible grades are not represented here as current commercial offerings. Grade options require their own specifications and testing.

05. Reference Lot YGIF26072101 — COA Results

The following values reproduce the reported reference COA and must not be presented as guaranteed results for future orders.

Analyte / property Specification Reference result
HPLC purity ≥99% 100.0% (as reported)
HPLC assay, dry basis 98.0–102.0% 99.82%
Melting point 189–190°C 189°C
Specific rotation [α]D25 Report actual value −23.53°
Loss on drying ≤1.0% 0.15%
Ethanol residual solvent <200 ppm 197 ppm
Mesh size 95% passing 60 mesh Conforms
Document status: manufacture 2026-07-21; report 2026-07-28; COA expiry 2029-07-20. Current-lot availability and original chromatograms are subject to verification.

06. HPLC Purity, Assay & Method Interpretation

The same COA reports HPLC purity 100.0% and dry-basis assay 99.82%. These are different measurements and should not be merged into a single marketing number. The report does not include a full batch-matched chromatogram, system suitability, integration report or calibration details.

An older Equol-3 HPLC report dated 26 November 2024 is available for historical method context only. Its result must not be used as a chromatographic record or purity confirmation for reference lot YGIF26072101.

Do not change the 2024 chromatogram date, sample ID or batch attribution. Obtain the analytical laboratory’s authenticated 2026 records before describing chromatographic traces as batch-matched.

07. Chiral Identity & Enantiomeric Purity

For an ingredient sold specifically as S-Equol, stereochemical identity is a primary qualification requirement. A buyer may request a validated chiral HPLC or comparable orthogonal method that resolves the S and R forms, with appropriate standards and peak identification.

  • Batch identifier and instrument/method version
  • Reference standards and retention/assignment evidence
  • S:R or enantiomeric purity result and reporting limit
  • Raw chromatogram, integration output and quality approval

Specific rotation supports identity when measurement conditions and method suitability are defined; it should not be treated alone as a quantitative percentage of the S enantiomer.

08. Physical Properties, Mesh & Powder Handling

The reference COA records a white crystalline powder, a measured melting point of 189°C and a conforming sieve result against 95% passing 60 mesh. An older company specification gives 100% passing 100 mesh, so these figures require grade/version reconciliation before a particle-size marketing promise is made.

If a micronized grade is needed, request sieve data or D10/D50/D90 laser-diffraction results for the offered lot. Flow, electrostatic behavior, compressibility and powder dust considerations should be validated in the customer’s process.

09. Feedstock Traceability: Daidzein and Fermentation

The upstream EquoPro™ supplier presentation describes production from daidzein by microbial fermentation and subsequent isolation/purification. This is a route description from a supplier document, not an independent site audit or proof that the reference lot used a particular strain or feedstock source.

Quality teams should request the manufacturing site, source of daidzein, strain and processing aid declarations where applicable, and chain-of-custody records. Related technical reading: S-Equol source and production guide.

10. Manufacturing Process & Purification Control

Typical evaluation checkpoints for an S-Equol biotransformation process include feedstock approval, controlled bioconversion, downstream separation, purification, crystallization and final release testing. Actual flowchart, critical control points and yield claims should be aligned to the identified producing facility.

  • Identity of actual legal manufacturer and manufacturing address
  • Batch traceability from incoming precursor to finished lot
  • Approved processing aids and any potential residual impurities
  • Contamination control, change control and reprocessing policy

Do not interpret the upstream supplier’s presentation of a patented production flow as evidence that AIHerba owns the process or the underlying intellectual property.

11. Quality Systems & Manufacturing-Site Qualification

The upstream presentation lists NSF, FSSC 22000, HACCP, ISO 22000, Halal, Kosher and other certifications. These are supplier claims and cannot be transferred to AIHerba as if issued to the same legal entity.

Buyers should request certificates showing exact company name, site address, accreditation or registration number, expiration date and product/process scope. AIHerba can coordinate collection of authorized supplier documentation as needed.

Supplier declaration: the reference COA is issued under Shaanxi Zhonghong Investment Technology Co., Ltd.; the supplier presentation is associated with Shanghai EGT SYNBIO. Their commercial and document relationship must be clarified before describing the site as owned or direct.

12. Residual Solvents, Metals & Microbiology

The reference batch COA provides residual ethanol <200 ppm specification with a result of 197 ppm. Elemental impurities including Pb, As, Cd and Hg are listed as “Conforms” against stated limits, rather than numerical measured values. Microbiological release tests are also reported as conforming.

Control Reference COA Qualification follow-up
Ethanol 197 ppm (<200 ppm) Full solvent panel and method / quantitation limit
Pb, As, Cd, Hg Conforms Quantitative ICP-MS results and detection limits
Total aerobic count Conforms (≤1,000 CFU/g) Actual result for supply lot
Yeast and mold Conforms (≤100 CFU/g) Actual result for supply lot
E. coli, Salmonella, S. aureus Not detected Batch method, sampling plan and certificate

USP test-procedure references do not, by themselves, prove compliance with every target market or finished-product use.

13. Carrier, Allergen & Composition Disclosure

The reference COA identifies S-Equol powder but does not provide an independent complete composition declaration identifying all carriers, excipients, processing aids or remaining soy-derived material. Consequently, “carrier-free,” “soy-free,” “organic,” and “non-GMO” require their own substantiation.

For sensitive formulations, the customer should obtain appropriate soy allergen, GMO and processing-aid statements issued by the actual manufacturer, where relevant.

14. Solubility & Formulation Compatibility

S-Equol is being evaluated in capsule, tablet, powdered nutrition and other specialty formulations. The supplied documents do not establish instant cold-water solubility, validated oil dispersibility or performance across specific pH, concentration and processing conditions.

  • Specify target concentration, solvent system and pH
  • Assess dissolution, uniformity and physical stability under use conditions
  • Validate compatibility with excipients, packaging and heat exposure
  • Use a grade-specific TDS rather than inferring performance from generic equol literature

Customer formula feasibility, finished-product stability and suitability are determined by application testing and destination-market requirements.

15. Storage, Shelf Life & Packaging

The 2026 reference COA states storage in a tight, light-resistant container, at controlled room temperature in a dry place, with a 36-month stated shelf life under proper conditions. The listed packaging uses an inner sterile bag and an outer aluminum-foil bag.

The COA expiry date is 20 July 2029. A full stability protocol and test data should be obtained before applying the same shelf-life claim across all grades and packages. The commercial pack weight, retest policy and dispatch lead time remain subject to confirmation.

16. Research & Product Development Context

Scientific literature has studied S-Equol and its interaction with estrogen-related signaling and biological processes. These studies motivate commercial R&D interest but should not be converted into unqualified treatment, menopause relief, cancer prevention or hormone-balancing claims for the offered ingredient.

For study summaries and their limitations, see the S-Equol clinical evidence and safety guide. Application-specific claims depend on validated finished-product data and applicable labeling rules.

17. U.S., EU & International Regulatory Qualification

Regulatory status must be evaluated for the precise material identity, production route, intended use, target population and destination country. A CAS entry, laboratory purity value or GMP certificate does not confer food, supplement, cosmetic or drug approval.

The FDA issued final recommendations on NDI identity and safety information on 19 October 2026. They describe notification documentation expectations, not approval of this S-Equol grade. EU authorization questions should be reviewed against the Novel Food Catalogue and the Union list and with local regulatory specialists.

FDA NDI Guidance (2026) · EU Novel Food Catalogue

18. Sampling, MOQ, Quotation & Commercial Supply

Qualification can begin with a document review and a requested analytical or formulation sample, subject to actual lot availability and sample permissions. MOQ, unit prices, country-specific import conditions, Incoterms, production lead time, packaging unit and delivery schedule require a written quotation.

Buyer input Why it matters
Grade and assay method Ensures the same material is being quoted
Required quantity and annual forecast Defines pilot or commercial tier
Destination country and intended use Regulatory and logistics screening
Required documentation Speeds QA qualification
Requested delivery terms Avoids assumptions about customs/taxes

For purchasing process guidance visit the S-Equol supplier qualification and bulk sourcing guide.

19. Supplier Qualification FAQ

What does ≥99% HPLC purity mean?

It is the stated chemical purity specification by the approved HPLC method; it is not proof of absolute purity or the S:R enantiomeric ratio.

Is the 2026 COA the current shipping batch?

Not confirmed. YGIF26072101 is the documented reference lot; request a current supply-lot COA.

Can the 2024 HPLC file support the 2026 lot?

No. It is an older Equol-3 sample with different testing and no established lot match.

Is a chiral HPLC report available?

A batch-linked report has not yet been supplied for independent verification; request confirmation.

Is the particle size 60 or 100 mesh?

The 2026 reference COA uses 95% pass 60 mesh; the older specification lists 100% pass 100 mesh. Confirm the offered grade and updated TDS.

Can the product be used in supplements worldwide?

No global approval is implied. The intended use and manufacturing identity require market-by-market regulatory review.

What is the documented packaging?

The reference COA states sterile inner bag and aluminum-foil outer bag; current commercial packaging weight requires confirmation.

20. References & Technical Disclaimer

Disclaimer: This page presents industrial ingredient technical qualification information. Reference results are not a guarantee of results for another batch. No therapeutic efficacy, regulatory clearance, organic origin, site certification or unverified manufacturing claim is implied.

DIRECT TECHNICAL CONSULTATION & BULK PROCUREMENT
Request Lot-Specific Documents & Formal Pricing

Send your target market, quantity, analytical requirements and project timeline. Email: sales@aiherba.com · WhatsApp: +86 199 2901 8987.

Ready to Evaluate This Ingredient?
GMP Certified
HPLC Lab Tested
Global Logistics
Samples Available
Scroll to Top

Request Factory-Direct Quote & Lab Samples

Access our 29-year R&D database. Batch-specific HPLC Fingerprints, COA & MSDS included. Standard samples dispatched via FedEx/DHL within 48h.

Request Factory-Direct Quote & Lab Samples